We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Covance Announces the Acquisition of Signet Laboratories

Read time: Less than a minute

Covance Research Products announced that it has acquired substantially all of the assets of Signet Laboratories, Inc.

Signet was created in 1989 as a commercial spinout of Johnson & Johnson's Cambridge Research Laboratories, Inc.

The Company was founded to continue the mission originally established at CRL - the early detection and recurrence monitoring of patients with cancer and infectious disease.

Signet has developed patented technology for diagnosis and recurrence monitoring and for risk assessment of asymptomatic patients in these areas.